
    
      Primary Objectives

        -  To evaluate the steady-state PK of CVC administered with and without DTG .

        -  To evaluate the steady-state PK of DTG administered with and without CVC .

        -  To evaluate the PK of a single dose of Midazolam administered with and without steady
           state CVC when both are administered orally.

      Secondary Objectives

        -  To evaluate the safety and tolerability of CVC administered with and without DTG.

        -  To evaluate the safety and tolerability of CVC administered with and without Midazolam.
    
  